A key insight is that EGCG can inhibit the activation of key receptor tyrosine kinases (RTKs) such as EGFR, HER2, and HER3, which are crucial for both cancer cell proliferation and cardiomyocyte survival signaling [199,200,201]. The gene discussed is ERBB2; the disease is cancer.